P/E ratio for Takara Bio (4974.T)
P/E ratio as of April 2025 (TTM): 7.38
According to Takara Bio's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 7.38075. At the end of 2023 the company had a P/E ratio of 13.0.
P/E ratio history for Takara Bio from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2023 | 13.0 | -6.37% |
| 2022 | 13.9 | -63.34% |
| 2021 | 37.8 | -46.9% |
| 2020 | 71.2 | -17.61% |
| 2019 | 86.4 | -17.55% |
| 2018 | 105 | -23.71% |
| 2017 | 137 | 1.54% |
| 2016 | 135 | -20.32% |
| 2015 | 170 | 51.7% |
| 2014 | 112 | 8.89% |
| 2013 | 103 | 94% |
| 2012 | 53.0 | -48.27% |
| 2011 | 102 | 3.04% |
| 2010 | 99.4 | 25.69% |
| 2009 | 79.1 | -23.36% |
| 2008 | 103 | -72.09% |
| 2007 | 370 | -546.78% |
| 2006 | -82.8 | -0.81% |
| 2005 | -83.4 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.